PMC:7212965 / 43921-44022 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T332","span":{"begin":17,"end":20},"obj":"http://purl.obolibrary.org/obo/CLO_0001046"}],"text":"in 13.79% (16 of 116) of the favipiravir group. Hepatotoxicity characterized by any elevation in AST "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T113","span":{"begin":29,"end":40},"obj":"Chemical"},{"id":"T114","span":{"begin":41,"end":46},"obj":"Chemical"},{"id":"T115","span":{"begin":97,"end":100},"obj":"Chemical"}],"attributes":[{"id":"A113","pred":"chebi_id","subj":"T113","obj":"http://purl.obolibrary.org/obo/CHEBI_134722"},{"id":"A114","pred":"chebi_id","subj":"T114","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A115","pred":"chebi_id","subj":"T115","obj":"http://purl.obolibrary.org/obo/CHEBI_76649"}],"text":"in 13.79% (16 of 116) of the favipiravir group. Hepatotoxicity characterized by any elevation in AST "}

{"project":"LitCovid-PubTator","denotations":[{"id":"1208","span":{"begin":29,"end":40},"obj":"Chemical"},{"id":"1214","span":{"begin":48,"end":62},"obj":"Disease"}],"attributes":[{"id":"A1208","pred":"tao:has_database_id","subj":"1208","obj":"MESH:C462182"},{"id":"A1214","pred":"tao:has_database_id","subj":"1214","obj":"MESH:D056486"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"in 13.79% (16 of 116) of the favipiravir group. Hepatotoxicity characterized by any elevation in AST "}